未知股票 TRVN 深 沪
已收盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 86.38万
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率 4.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多HC Wainwright & Co. Downgrades Trevena to Neutral, Maintains $5 Price Target
HC Wainwright & Co. analyst Douglas Tsao downgrades Trevena (OTC:TRVN) from Buy to Neutral and maintains $5 price target.
2024-11-15 02:51
Crude Oil Gains Over 3%; Scholar Rock Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Dow Jones index falli...
2024-10-08 00:00
Why Trevena (TRVN) Stock Is Down 43% Today
Trevena shares are trading lower by 47% during Monday's session. The company announced it received a Nasdaq delisting notification.
2024-10-07 22:38
US Stocks Open Lower; Dow Tumbles Over 150 Points
U.S. stocks traded lower this morning, with the Dow Jones falling more than 150...
2024-10-07 21:47
Market-Moving News for October 7th
SRRK: 382% | Scholar Rock Holding shares are trading higher after the company announced topline results from the Phase 3 SAPPHIRE clinical trial evaluating the efficacy and safety of apitegromab in patients with
2024-10-07 20:08
Trevena Faces Nasdaq Delisting and Uncertain OTC Future
Trevena ( ($TRVN) ) has shared an update. Trevena, Inc., a biopharmaceutical co...
2024-10-05 04:34
Trevena receives Nasdaq delisting notification
Trevena (NASDAQ:TRVN) announced that on October 4, 2024 the company received notice that the Nasdaq hearings panel had determined to delist the company’s common stock from Nasdaq Stock Market. As prev...
2024-10-05 04:24
Trevena Receives Receipt Of Nasdaq Delisting Notification
Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that on October 4,
2024-10-05 04:05
Reported Earlier, Trevena Q2 EPS $(0.23) Beats $(0.40) Estimate, Sales $325.00K Down From $3.02M YoY
Trevena (NASDAQ:TRVN) reported quarterly losses of $(0.23) per share which beat...
2024-08-09 05:35
Trevena Announces 1-For-25 Reverse Stock Split, Effective Tuesday, August 13, 2024
Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that it has filed a
2024-08-09 05:34
